4//SEC Filing
van den Broek Richard 4
Accession 0001169245-23-000033
CIK 0001169245other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:18 PM ET
Size
7.1 KB
Accession
0001169245-23-000033
Insider Transaction Report
Form 4
van den Broek Richard
Director
Transactions
- Award
Common Stock
2023-05-19+3,750→ 0 total - Exercise/Conversion
Restricted Stock Units
2023-05-19−3,750→ 0 total→ Common Stock (3,750 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock.
- [F2]The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001431872
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:18 PM ET
- Size
- 7.1 KB